Top 10 Drug Interactions Every Doctor Should Know

Introduction

Drug-drug interactions (DDIs) are a significant cause of adverse drug reactions, hospital admissions, and treatment failure. In Pakistan, where polypharmacy is common, particularly in elderly patients with multiple comorbidities, awareness of key interactions is essential.

1. Warfarin + NSAIDs

**Risk**: Major — significantly increased bleeding risk

**Mechanism**: NSAIDs inhibit platelet function and cause GI mucosal damage; warfarin inhibits clotting factor synthesis

**Management**: Avoid combination if possible. If unavoidable, use lowest effective dose of short-acting NSAID (e.g., ibuprofen) with PPI cover. Monitor INR closely.

2. ACE Inhibitors + Potassium-Sparing Diuretics

**Risk**: Moderate — life-threatening hyperkalemia

**Mechanism**: ACE inhibitors reduce aldosterone, decreasing K+ excretion; K-sparing diuretics (spironolactone, amiloride) further impair K+ excretion

**Management**: Avoid combination. If necessary, use low doses, monitor serum K+ and renal function frequently.

3. Clarithromycin + Statins

**Risk**: Major — rhabdomyolysis

**Mechanism**: Clarithromycin inhibits CYP3A4, dramatically increasing statin (atorvastatin, simvastatin) levels

**Management**: Consider alternative macrolide (azithromycin) or hold statin during clarithromycin course. Atorvastatin dose should not exceed 20 mg/day during therapy.

4. Metformin + Contrast Media

**Risk**: Moderate — lactic acidosis

**Mechanism**: IV contrast can precipitate acute kidney injury, reducing metformin clearance

**Management**: Hold metformin 48 hours before elective contrast studies. Restart 48 hours post-procedure if renal function stable.

5. Digoxin + Amiodarone

**Risk**: Major — digoxin toxicity

**Mechanism**: Amiodarone reduces digoxin clearance and displaces digoxin from tissue binding sites

**Management**: Reduce digoxin dose by 50% when starting amiodarone. Monitor digoxin levels and for signs of toxicity (arrhythmias, GI symptoms, visual disturbances).

6. Fluoroquinolones + NSAIDs

**Risk**: Moderate — increased CNS toxicity, seizure risk

**Mechanism**: NSAIDs enhance GABA receptor antagonism of fluoroquinolones

**Management**: Avoid combination, particularly in elderly patients and those with seizure history. Consider alternative antibiotics.

7. Methotrexate + Trimethoprim-Sulfamethoxazole

**Risk**: Major — severe myelosuppression

**Mechanism**: Both drugs inhibit dihydrofolate reductase, causing additive folate depletion

**Management**: Avoid this combination. If unavoidable, use with extreme caution, monitor CBC closely, and supplement with folinic acid.

8. SSRIs + MAOIs

**Risk**: Major — serotonin syndrome (hyperthermia, rigidity, autonomic instability)

**Mechanism**: Additive serotonin excess

**Management**: Absolute contraindication. Requires 14-day washout when switching between classes.

9. Theophylline + Ciprofloxacin

**Risk**: Major — theophylline toxicity (seizures, arrhythmias)

**Mechanism**: Ciprofloxacin inhibits CYP1A2, reducing theophylline clearance by 30-50%

**Management**: Reduce theophylline dose by 30-50% when starting ciprofloxacin. Monitor theophylline levels.

10. Clopidogrel + Omeprazole

**Risk**: Moderate — reduced clopidogrel efficacy

**Mechanism**: Omeprazole inhibits CYP2C19, reducing conversion of clopidogrel to its active metabolite

**Management**: Use pantoprazole or famotidine instead of omeprazole for acid suppression in patients on clopidogrel.

General Principles for Avoiding Interactions

**Disclaimer**: This article is for educational purposes only. Always verify interactions using up-to-date clinical resources.